Home
Ultragenyx Pharmaceutical RARE spent $110K on lobbying in Q4 2024 · Health Issues, Budget and 1 more issue
Trade details
- Type
- Lobbying report
- Amount
- $110,000
- Quarter
- Q4 2024
- Reported
- 25/01/20
Up 37.5% from last quarter
What else happened in Ultragenyx Pharmaceutical around then
Filed or reported within 30 days of the trade day · 24/12/01~25/01/30Ultragenyx Pharmaceutical's other lobbying reports
- Ultragenyx Pharmaceutical
LobbyingUltragenyx Pharmaceutical
LobbyingUltragenyx Pharmaceutical
RARE
$30K
$30K
Reported 07/20
for Q2
- Ultragenyx Pharmaceutical
LobbyingUltragenyx Pharmaceutical
LobbyingUltragenyx Pharmaceutical
RARE
$390K
$390K
Reported 07/20
for Q2
- Ultragenyx Pharmaceutical
LobbyingUltragenyx Pharmaceutical
LobbyingUltragenyx Pharmaceutical
RARE
$40K
$40K
Reported 07/20
for Q1
- Ultragenyx Pharmaceutical
LobbyingUltragenyx Pharmaceutical
LobbyingUltragenyx Pharmaceutical
RARE
$60K
$60K
Reported 07/20
for Q2
- Ultragenyx Pharmaceutical
LobbyingUltragenyx Pharmaceutical
LobbyingUltragenyx Pharmaceutical
RARE
$140K
$140K
Reported 07/20
for Q2